Boosted by Adidas, DAX reaches a fresh record high

Published 2025-01-22, 03:46 a/m
© Reuters.
ADSGN
-
DE30
-
STOXX
-

Investing.com -- European stocks saw further gains on Wednesday, with Adidas (OTC:ADDYY)' robust holiday-quarter results driving German shares to unprecedented heights, and healthcare stocks also showing impressive gains. The pan-European STOXX 600 rose by 0.5% and was trading at its highest level since Sept. 27, 2024, as of 0822 GMT.

The rise was primarily led by heavyweight healthcare stocks that increased by 1.1%. This boost was further supported by a 2.7% surge in the shares of drugmaker Novo Nordisk (NYSE:NVO).

Adidas' shares saw a significant 6% increase after the German sportswear brand announced its preliminary fourth-quarter results, which surpassed expectations. The company attributed these strong results to high sales and profitability during the crucial holiday shopping period.

Following Adidas' lead, Puma (OTC:PMMAF)'s shares also rose by 2.5%. Germany's benchmark index outperformed its regional counterparts by adding 0.9%, reaching a record high.

The market's positive trend continued despite U.S. President Donald Trump's pledge to impose new tariffs on the European Union. The Trump administration also discussed imposing a 10% tariff on Chinese goods starting Feb. 1.

In contrast, shares of Schaeffler, the German automotive supplier, experienced a substantial 15% drop. This decline came after the company reported preliminary results for 2024 that fell short of expectations.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.